Dr. John studies metabolism in the setting of pediatric infections, in order to identify new anti-infective drug targets, understand drug resistance, and develop new diagnostics.
Dr. Puopolo helped lead the research team that developed and validated multivariate prediction models for neonatal early-onset sepsis risk assessment. Her current research addresses the impacts of maternal immunity, perinatal antibiotic exposure, and neonatal infection on infant and childhood health.
CHOP researchers found neighborhood characteristics were associated with higher rates of SARS-CoV-2 in pregnancy during the prevaccination era of the COVID-19 pandemic
